期刊文献+

Peroxiredoxin 1与EMT相关蛋白在胰腺癌组织中的表达及其临床意义 被引量:6

Clinical significance of expression of Peroxiredoxin 1 and EMT related factors in pancreatic carcinoma
下载PDF
导出
摘要 目的探讨过氧化物还原酶1(Prx1)与上皮细胞间质转化(EMT)相关蛋白在胰腺癌组织中的表达及其临床意义。方法采用免疫组化法分别检测Prx1、E-钙黏素(Ecadherin)、波形蛋白(Vimentin)在66例胰腺癌组织和11例正常胰腺组织中的表达,并分析三者之间的关系及与临床病理因素间的关系。结果 Prx1、E-cadherin和Vimentin分别在66例胰腺癌组织中的阳性表达率为69.70%(46/66)、40.91%(27/66)、56.06%(37/66);Prx1、E-cadherin和Vimentin分别在11例正常胰腺组织中的阳性表达率为18.18%(2/11)、90.90%(10/11)、18.18%(2/11)。Prx1、E-cadherin和Vimentin在胰腺癌组织中的表达均与TNM分期、淋巴结转移和肿瘤分化程度显著相关(P<0.05),而与性别、年龄、肿瘤大小、病变部位均无关;Prx1与神经侵犯显著相关(P<0.05),而E-cadherin和Vimentin与神经侵犯无关。Prx1的表达与Vimentin表达呈正相关(P<0.05),Prx1和Vimentin的表达均与E-cadherin表达呈负相关(P<0.05)。结论Prx1与EMT相关蛋白在胰腺癌组织中的表达呈显著相关性,并与其侵袭转移能力相关,提示Prx1的高表达可能为预测胰腺癌患者预后不良的辅助指标之一。 Objective To investigate the expression clinical significance of Peroxiredoxin 1 (Prxl) and epithelial mesenchymal transition (EMT) -related factors in pancreatic carcinoma. Methods The expression of Prxl, E-cad- herind and Vimentin were detected in 66 pancreatic carcinoma samples and 11 normal pancreatic tissues by immu- nohistochemical method. The correlation between Prxl, E-cadherin, Vimentin and clinicopathologic characteristics was also analyzed. Results The positive expression rates of Prxl, E-cadherind and Vimentin were 69.70% (46/ 66), 40. 91% (27/66) and 56.06% (37/66) in pancreatic carcinoma, and 18.18% (2/11), 90.90% ( 10/ 11 ) and 18. 18% (2/11) in normal pancreatic tissue, respectively. The expression rates of Prxl, E-cadherin and Vimentin were correlated with TNM stage, lymph node metastasis, degree of differentiation ( P 〈 0. 05 ). Prxl expression was correlated with nerve invasion in pancreatic carcinoma tissue (P 〈 0. 05 ). The expression rates of Prxl, E-cadherin and Vimentin were not correlated with sex, age, size, site of tumor. E-cadherin and ~imentin expression were not correlated with nerve invasion inpancreatic carcinoma tissue. Prxl expression in pancreatic car- cinoma was positively correlated with Vimentin expression (P 〈 0. 05 ) ; Prxl and Vimentin were negatively correla- ted with E-cadherin expression (P 〈 0. 05). Conclusion Prxl, E-cadherin and Vimentin expressions are associ- ated with the ability of invasion and metastasis in pancreatic carcinoma, Prxl abnormal expression maybe serve as a potential poor prognostic marker of patients with pancreatic carcinoma.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第3期368-372,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81272740)
关键词 胰腺癌 过氧化物还原酶1 E-钙黏素 波形蛋白 pancreatic carcinoma Peroxiredoxin 1 E-cadherind Vimentin
  • 相关文献

参考文献8

  • 1Ha B,Kim E K,Kim J H,et al. Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its per- oxidase activity ~ J ]. Biochem Biophys Res Commun, 2012, 421 (1) :33 -7.
  • 2Yonglitthipagon P, Pairojkul C, Charngramol Y, et al. Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma[ J]. Hum Pathol,2012, 43(10) :1719 -30.
  • 3Sun Q K, Zhu J Y, Wang W, et al. Diagnostic and prognostic signif- icance of peroxiredoxin 1 expression in human hepatoeellular carci- noma[J]. Med Oncol, 2014, 31(1) :786.
  • 4Neumann C A, Cao J, Manevich Y,et al. Peroxiredoxin 1 and its role in cell signaling[ J ]. Cell Cycle, 2009, 8 (24) :4072 -8.
  • 5Li J, Yang Z L, Ren X,et al. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adeno- carcinoma of gallbladder [ J ]. Turnout Biol, 2013, 34 ( 1 ) :359 - 68.
  • 6De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression[ JJ. Nat Rev Cancer, 2013, 13 (2) :97 - 110.
  • 7Handra-Luea A, Hong S M, Walter K, et al. Tumour epithelial vi- mentin expression and outcome of pancreatic cluctal adenocarcino- mas[J]. Br J Cancer, 2011, 104(8) :1296 -302.
  • 8Roy L D, Sahraei M, Subramani D B,et al. MUC1 enhances inva- siveness of pancreatic cancer cells by inducing epithelial to mesen- chymal transition [ J ]. Oncogene, 2011,30 (12) : 1449 - 59.

同被引文献54

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部